Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland.
J Int AIDS Soc. 2020 Feb;23(2):e25449. doi: 10.1002/jia2.25449.
INTRODUCTION: The availability of potent antiretroviral therapy has transformed HIV infection into a chronic disease such that people living with HIV (PLWH) have a near normal life expectancy. However, there are continuing challenges in managing HIV infection, particularly in older patients, who often experience age-related comorbidities resulting in complex polypharmacy and an increased risk for drug-drug interactions. Furthermore, age-related physiological changes may affect the pharmacokinetics and pharmacodynamics of both antiretrovirals and comedications thereby predisposing elderly to adverse drug reactions. This review provides an overview of the therapeutic challenges when treating elderly PLWH (i.e. >65 years). Particular emphasis is placed on drug-drug interactions and other common prescribing issues (i.e. inappropriate drug use, prescribing cascade, drug-disease interaction) encountered in elderly PLWH. DISCUSSION: Prescribing issues are common in elderly PLWH due to the presence of age-related comorbidities, organ dysfunction and physiological changes leading to a higher risk for drug-drug interactions, drugs dosage errors and inappropriate drug use. CONCLUSIONS: The high prevalence of prescribing issues in elderly PLWH highlights the need for ongoing education on prescribing principles and the optimal management of individual patients. The knowledge of adverse health outcomes associated with polypharmacy and inappropriate prescribing should ensure that there are interventions to prevent harm including medication reconciliation, medication review and medication prioritization according to the risks/benefits for each patient.
简介:高效抗逆转录病毒疗法的出现使 HIV 感染转变为一种慢性病,从而使 HIV 感染者(PLWH)的预期寿命接近正常。然而,在管理 HIV 感染方面仍存在持续的挑战,特别是在老年患者中,他们经常患有与年龄相关的合并症,导致复杂的多药物治疗和药物相互作用风险增加。此外,与年龄相关的生理变化可能会影响抗逆转录病毒药物和合并用药的药代动力学和药效学,从而使老年人易发生药物不良反应。本文综述了治疗老年 PLWH(即>65 岁)时的治疗挑战。特别强调了药物-药物相互作用和老年 PLWH 中常见的其他处方问题(即不适当的药物使用、处方级联、药物-疾病相互作用)。 讨论:由于与年龄相关的合并症、器官功能障碍和生理变化的存在,老年 PLWH 中常见处方问题,导致药物-药物相互作用、药物剂量错误和不适当的药物使用风险更高。 结论:老年 PLWH 中普遍存在处方问题,这突出表明需要不断进行处方原则教育和个体化患者的最佳管理。了解与多药物治疗和不适当处方相关的不良健康后果,应确保采取干预措施预防危害,包括根据每位患者的风险/获益进行药物重整、药物审查和药物优先化。
J Int AIDS Soc. 2020-2
Expert Rev Clin Pharmacol. 2019-6-19
Expert Rev Clin Pharmacol. 2018-11-26
J Antimicrob Chemother. 2021-2-11
J Manag Care Spec Pharm. 2014-8
Drugs. 2025-5-12
Biomed Pharmacother. 2025-3
J Acquir Immune Defic Syndr. 2019-11-1
Expert Rev Clin Pharmacol. 2019-6-19
CPT Pharmacometrics Syst Pharmacol. 2019-7